Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude’s Epic Year Wins Over Investors; MDDI Index Up 15% In 2004

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical's entry into the cardiac resynchronization therapy ICD market and expanded atrial fibrillation business helped capture the attention of Wall Street and potential suitors in 2004 as its stock jumped 37% for the year

You may also be interested in...



St. Jude PFO Program For Stroke, Migraine Gets Boost With Velocimed Deal

St. Jude Medical will accelerate its patent foramen ovale (PFO) R&D program for stroke treatment by acquiring Velocimed for more than $82.5 mil. under a definitive agreement, the firms said Feb. 15

St. Jude Fortifies AF Business With HIFU Market Development, R&D Initiatives

The president of St. Jude Medical's fledgling AF division, Jane Song, is tasked with establishing 10-15 "centers of excellence" in preparation for the firm's high intensity focused ultrasound (HIFU) launch

St. Jude PFO Program For Stroke, Migraine Gets Boost With Velocimed Deal

St. Jude Medical will accelerate its patent foramen ovale (PFO) R&D program for stroke treatment by acquiring Velocimed for more than $82.5 mil. under a definitive agreement, the firms said Feb. 15

Related Content

UsernamePublicRestriction

Register

MT021424

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel